FTO and gastric cancer: High expression of METTL3, METTL14, FTO, YTDHF1-2 and IGF2BP1, in gastric cancer, facilitates tumor immune evasion by maintaining the stability and expression of PD-L1 transcripts [123,124,125,126,127].